EUR/USD 1.18153
0.158%
Gold 5263.32
1.523%
Oil 67.175
2.731%
USD/JPY 156.171
0.028%
GBP/USD 1.34769
-0.043%
GBP/JPY 210.475
-0.006%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Initial reports indicate that several missiles struck Jomhuri Avenue.Foreign airline flights bound for Israel have begun returning to their origin.On February 28th, according to the National Medical Products Administration (NMPA), a symposium on rare disease drug research and development, themed "Caring First," was held at the NMPAs Center for Drug Evaluation. The meeting noted that in recent years, the NMPA has continuously strengthened the guarantee of drugs for rare diseases, implementing a comprehensive policy package and establishing and streamlining three channels: encouraging innovation, accelerating drug introduction, and temporary import. As a result, the number and speed of rare disease drugs approved for marketing in my country have significantly increased. In 2025 alone, 48 rare disease drugs were approved for marketing, allowing more patients to simultaneously enjoy internationally advanced treatments and medications. The meeting emphasized that solving problems in the field of rare diseases urgently requires greater institutional innovation and resource integration. The NMPA will continue to strengthen policy supply and enhance service support in the review and approval process. Simultaneously, it will strengthen multi-party collaboration, build consensus and synergy, and promote the application of new technologies and products.Market news: Two powerful explosions occurred in Jalalabad, Afghanistan.Israel Defense Forces: We will never allow Hezbollah to rebuild its strength.

Stock Markets Continue to Put Up a Fight

Cory Russell

Jul 18, 2022 15:12

微信截图_20220718150741.png

Weekly Technical Analysis for the S&P 500

The S&P 500 has declined considerably over the last week, but it's important to remember that the previous three candlesticks have all been hammers, which does indicate that a balance or perhaps a breakout to show signs of life is very approaching. Having said that, I believe the market will, more often than not, exhibit a scenario in which there will be a brief rebound and maybe a bid to test the 4200 level. If we could break through the 4200 level, which has served as a big area of resistance as well, the general trend would alter.


On the other side, this market is likely to crash very severely if we reverse course and break down below the 3640 level and, therefore, the 200 day EMA. Given everything being equal, I think this market is a touch oversold, so a little rebound makes some sense. The market will likely continue to be choppy and noisy, and you should be concerned about the fact that we are almost certainly heading into a recession, despite what some people on Wall Street would have you believe. Keep in mind that we are about to enter the earnings season, so you need to pay close attention to pre-market volatility.


In the end, I believe fading rallies will continue to be effective, but we must wait for those rallies to take place in order to get some opportunity and a better risk-to-reward ratio.

Suggestion